#cafc

#cafc

SC Johnson's primary noninfringement argument was that its products do not include a "spout." Before the district court, both Zip Top and SC Johnson agreed that the spout claim element should be construed as a "distinct feature that directs liquid from and facilitates the pouring of fluid from a container." The dispute on appeal arose from an additional limitation the district court imposed, finding that "the zipper members are not the spout or part of it; rather, the spout is a separate feature."

In January 2024, EFF contacted Entropic and Charter requesting that both parties file motions establishing reasons to justify the ongoing secrecy of redacted documents regarding the DOCSIS standard and non-infringing alternatives. After a meet-and-confer that same month with all three parties was unfruitful, EFF moved to intervene in the case and unseal records in March 2024. That motion was denied as untimely by the Eastern Texas district court due to EFF's four-month delay in filing

The U.S. Court of Appeals for the Federal Circuit affirmed that Teva Pharmaceuticals did not prove the claims of Janssen Pharmaceuticals' patent for antipsychotic dosing regimens invalid for obviousness.